Background illustration for clinical trials search

Multiple Sclerosis Clinical Trials

Browse 309 multiple sclerosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.

for
Multiple Sclerosis
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07115017

Recruiting

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

for
Multiple Sclerosis, Depression
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 65

Code: NCT06901687

Phase 2, Recruiting

Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

for
Multiple Sclerosis, Hypertension
Location: Boston MA
Sponsor: University of Massachusetts, Boston

Sex: All

Age: 18+

Code: NCT06554340

Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

for
Multiple Sclerosis Spasticity
Location: Foxborough MA, Levis, Montreal, Philadelphia PA, Ottawa,
Sponsor: Celgene

Sex: All

Age: 18 - 70

Code: NCT06782490

Phase 2, Recruiting

Deciphering Preserved Autonomic Function After Multiple Sclerosis

for
Multiple Sclerosis, Control Subjects, Autonomic Dysreflexia
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 50

Code: NCT07012135

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Foxborough MA, Burlington MA, Levis, Teaneck NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

Skeletal Muscle Aging and Responsiveness in Aged People With MS

for
Multiple Sclerosis, Aging
Location: Oklahoma City OK
Sponsor: Oklahoma Medical Research Foundation

Sex: All

Age: 60+

Code: NCT07500727

Recruiting

Remote Evaluation of MIND Diet

for
Multiple Sclerosis, Cognitive Change, Nutrition, Healthy
Location: Urbana IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 18 - 64

Code: NCT06450977

Recruiting

High Intensity Interval Gait Training in Multiple Sclerosis

for
Multiple Sclerosis,Gait, Exercise
Location: New York NY
Sponsor: City University of New York

Sex: All

Age: 18 - 70+

Code: NCT05529498

Recruiting

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

for
Multiple Sclerosis
Location: Durham NC, Aurora CO
Sponsor: Biogen

Sex: Female

Age: 0+

Code: NCT05658497

Recruiting

Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection

for
Multiple Sclerosis, Insomnia
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18 - 65

Code: NCT06434571

Phase 2, Recruiting

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

for
Multiple Sclerosis
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT06410261

Recruiting

Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis

for
Multiple Sclerosis
Location: Boston MA
Sponsor: MGH Institute of Health Professions

Sex: All

Age: 25 - 70+

Code: NCT06136728

Phase 3, Recruiting

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

for
Multiple Sclerosis, Sleep, Pain
Location: Ann Arbor MI
Sponsor: Tiffany J. Braley, MD, MS

Sex: All

Age: 18 - 65

Code: NCT05269628

Phase 2, Recruiting

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

for
Multiple Sclerosis
Location: Teaneck NJ
Sponsor: Holy Name Medical Center, Inc.

Sex: All

Age: 18+

Code: NCT03424733

Recruiting

Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community

for
Multiple Sclerosis
Location: East Hanover NJ
Sponsor: Kessler Foundation

Sex: All

Age: 19 - 65

Code: NCT06608797

Recruiting

KITAMS: Kinesio Tape and Physical Function in Persons With Multiples Sclerosis

for
Multiple Sclerosis
Location: DeKalb IL
Sponsor: Northern Illinois University

Sex: All

Age: 18 - 50

Code: NCT03804047

Recruiting

Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis

for
Multiple Sclerosis
Location: Greenfield Park, Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT01891071

Recruiting

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

for
Multiple Sclerosis
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03109288

Phase 1, Phase 2, Recruiting

The Effect of Motor Imagery on Balance in Persons With Multiple Sclerosis

for
Falls, Motor Imagery, Multiple Sclerosis, Balance, Fatigue
Location: Orangeburg NY
Sponsor: Dominican University New York

Sex: All

Age: 0+

Code: NCT05615207

Recruiting

What is multiple sclerosis?

In MS, the immune system attacks myelin, the insulation around nerve fibers in the brain and spinal cord. Damaged spots, called lesions, slow or block nerve signals, which is why symptoms range from fatigue and numbness to vision problems and trouble walking. Symptoms and pace differ so much between people that MS is often called a disease with a thousand faces. It is not contagious, and it is not directly inherited. Worldwide about 2.9 million people live with MS, someone is diagnosed roughly every five minutes, and the average age at diagnosis is 32.

Research in this field carries one of the most striking findings in modern medicine: a 2022 study of more than 10 million US military members found that infection with the Epstein Barr virus, the common virus behind mononucleosis, raises MS risk 32 times, making it the leading suspected cause. Meanwhile treatment keeps expanding, with more than 20 approved disease modifying therapies, though the progressive forms still have almost none.

Article preview image

Interested in learning more about MS treatment? Read our guide: Multiple Sclerosis Treatment: 20+ Drugs and What's Next

Why Progressive Multiple Sclerosis Still Has Almost No Approved Treatments

The types of MS, and why they matter for trials

Types of multiple sclerosis clinical trials

Who can participate in MS trials?

Do MS trial participants get paid?

How to enroll in a clinical trial for multiple sclerosis